BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24855205)

  • 1. Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system.
    Zacchigna S; Zentilin L; Giacca M
    Circ Res; 2014 May; 114(11):1827-46. PubMed ID: 24855205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
    Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
    Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.
    Cunningham SC; Siew SM; Hallwirth CV; Bolitho C; Sasaki N; Garg G; Michael IP; Hetherington NA; Carpenter K; de Alencastro G; Nagy A; Alexander IE
    Hepatology; 2015 Aug; 62(2):417-28. PubMed ID: 26011400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
    Poller W; Tank J; Skurk C; Gast M
    Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing gene delivery vectors for cardiovascular gene therapy.
    Baker AH
    Prog Biophys Mol Biol; 2004; 84(2-3):279-99. PubMed ID: 14769440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
    Ulrich-Vinther M
    Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.
    Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF
    J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated viral vectors for gene transfer and gene therapy.
    Büeler H
    Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trends in development of self-complementary adeno-associated virus vector].
    Lü Y; Wang Q; Xiao W; Diao Y; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):658-64. PubMed ID: 19670632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advancements in Cardiovascular Gene Therapy and Vascular Biology.
    Laakkonen JP; Ylä-Herttuala S
    Hum Gene Ther; 2015 Aug; 26(8):518-24. PubMed ID: 26192706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-selective viral gene delivery vectors for the vasculature.
    Baker AH; Kritz A; Work LM; Nicklin SA
    Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus vectors: versatile tools for in vivo gene transfer.
    Zentilin L; Giacca M
    Contrib Nephrol; 2008; 159():63-77. PubMed ID: 18391585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation.
    Rincon MY; VandenDriessche T; Chuah MK
    Cardiovasc Res; 2015 Oct; 108(1):4-20. PubMed ID: 26239654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus vectors for gene transfer to the brain.
    Okada T; Nomoto T; Shimazaki K; Lijun W; Lu Y; Matsushita T; Mizukami H; Urabe M; Hanazono Y; Kume A; Muramatsu S; Nakano I; Ozawa K
    Methods; 2002 Oct; 28(2):237-47. PubMed ID: 12413422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy.
    Adriaansen J; Tas SW; Klarenbeek PL; Bakker AC; Apparailly F; Firestein GS; Jorgensen C; Vervoordeldonk MJ; Tak PP
    Ann Rheum Dis; 2005 Dec; 64(12):1677-84. PubMed ID: 15878906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene therapy of neurological diseases].
    Kahn A; Haase G; Akli S; Guidotti JE
    C R Seances Soc Biol Fil; 1996; 190(1):9-11. PubMed ID: 8881264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.